A recent analysis of the World Health Organizations pharmacovigilance database, VigiBase, found that there was an increased risk of suicidal ideation for patients taking semaglutide, liraglutide, and tirzepatide (Mounjaro, Zepbound) as compared with other medications for diabetes
June 2026: There are 110 lawsuits that have been filed or transferred into the GLP-1 NAION MDL, an increase of 24 from Mays case count
A 48-week treatment period plus a 2-3 month washout exceeds that window
Ecnoglutide 1.2 mg, 1.8 mg, and 2.4 mg resulted in 9.1%, 10.9%, and 13.2% weight loss, respectively, after 40 weeks, compared to 0.1% weight gain in the placebo group [29]
Cosmetic procedures are proven to be more effective when they are used in conjunction with other treatments
View Treatment Options What are the benefits of Sermorelin injections